Show simple item record

dc.contributor.authorBayman, Neil A
dc.contributor.authorArdron, D
dc.contributor.authorAshcroft, Linda
dc.contributor.authorBaldwin, D
dc.contributor.authorBooton, R
dc.contributor.authorDarlison, L
dc.contributor.authorEdwards, J
dc.contributor.authorLang-Lazdunski, L
dc.contributor.authorLester, J
dc.contributor.authorPeake, M
dc.contributor.authorRintoul, R
dc.contributor.authorSnee, M
dc.contributor.authorTaylor, Paul
dc.contributor.authorLunt, C
dc.contributor.authorFaivre-Finn, Corinne
dc.date.accessioned2016-02-18T15:06:50Zen
dc.date.available2016-02-18T15:06:50Zen
dc.date.issued2016en
dc.identifier.citationProtocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention. 2016, 6 (1):e010589 BMJ Openen
dc.identifier.issn2044-6055en
dc.identifier.pmid26817643en
dc.identifier.doi10.1136/bmjopen-2015-010589en
dc.identifier.urihttp://hdl.handle.net/10541/596613en
dc.description.abstractHistological diagnosis of malignant mesothelioma requires an invasive procedure such as CT-guided needle biopsy, thoracoscopy, video-assisted thorascopic surgery (VATs) or thoracotomy. These invasive procedures encourage tumour cell seeding at the intervention site and patients can develop tumour nodules within the chest wall. In an effort to prevent nodules developing, it has been widespread practice across Europe to irradiate intervention sites postprocedure-a practice known as prophylactic irradiation of tracts (PIT). To date there has not been a suitably powered randomised trial to determine whether PIT is effective at reducing the risk of chest wall nodule development.
dc.language.isoenen
dc.rightsArchived with thanks to BMJ openen
dc.titleProtocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention.en
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UKen
dc.identifier.journalBMJ Openen
html.description.abstractHistological diagnosis of malignant mesothelioma requires an invasive procedure such as CT-guided needle biopsy, thoracoscopy, video-assisted thorascopic surgery (VATs) or thoracotomy. These invasive procedures encourage tumour cell seeding at the intervention site and patients can develop tumour nodules within the chest wall. In an effort to prevent nodules developing, it has been widespread practice across Europe to irradiate intervention sites postprocedure-a practice known as prophylactic irradiation of tracts (PIT). To date there has not been a suitably powered randomised trial to determine whether PIT is effective at reducing the risk of chest wall nodule development.


This item appears in the following Collection(s)

Show simple item record